
Prologis, Teledyne Technologies, Ascendis Pharma A/S, Hamilton Lane, Hercules Capital, Tyra Biosciences, and Trinity Capital are the seven Growth stocks to watch today, according to MarketBeat’s stock screener tool. Growth stocks are shares of companies expected to grow revenue and earnings faster than the overall market, often because they operate in expanding industries or have scalable products and services. They typically reinvest profits rather than pay dividends and trade at higher valuation multiples based on anticipated future growth, which can lead to greater long-term return potential but also higher volatility and risk. These companies had the highest dollar trading volume of any Growth stocks within the last several days.
Prologis (PLD)
Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. At March 31, 2024, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 1.2 billion square feet (115 million square meters) in 19 countries.
Teledyne Technologies (TDY)
Teledyne Technologies Incorporated, together with its subsidiaries, provides enabling technologies for industrial growth markets in the United States and internationally. Its Digital Imaging segment provides visible spectrum sensors and digital cameras; and infrared, ultraviolet, visible, and X-ray spectra; as well as micro electromechanical systems and semiconductors, including analog-to-digital and digital-to-analog converters.
Read Our Latest Research Report on TDY
Ascendis Pharma A/S (ASND)
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapies for unmet medical needs. It offers SKYTROFA for treating patients with growth hormone deficiency (GHD). The company is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates.
Read Our Latest Research Report on ASND
Hamilton Lane (HLNE)
Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.
Read Our Latest Research Report on HLNE
Hercules Capital (HTGC)
Hercules Capital, Inc. is a business development company. The firm specializing in providing venture debt, debt, senior secured loans, and growth capital to privately held venture capital-backed companies at all stages of development from startups to expansion stage including select publicly listed companies and select special opportunity lower middle market companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies.
Read Our Latest Research Report on HTGC
Tyra Biosciences (TYRA)
Tyra Biosciences, Inc., a clinical-stage biotechnology company, develops precision medicines for fibroblast growth factor receptor (FGFR) biology in the United States. The company offers SNÅP, a precision medicine platform that enables drug design through iterative molecular snapshots to predict genetic alterations for developing therapies targeting oncology and genetically defined conditions.
Read Our Latest Research Report on TYRA
Trinity Capital (TRIN)
Read Our Latest Research Report on TRIN
Further Reading
- MarketBeat’s Top Five Stocks to Own in February 2026
- Qualcomm’s Analysts Are Throwing in the Towel—Time to Be Brave?
- 3 Discount Retail Stocks to Watch as Earnings Put Valuations to the Test
- CRWD Stock: Buy the Dip or Beware the Valuation?
- 3 Overlooked Dividend Stocks for Choppy Markets in 2026
- Is SentinelOne’s Sell-Off a Warning Sign or an Opportunity?
